Split History
ETFs Holding CBRX »    CBRX Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Juniper Pharmaceuticals is engaged in in the business of developing, licensing, manufacturing and selling to its marketing partners pharmaceutical products that utilize its drug delivery technologies to treat various medical conditions. Co.'s products include bioadhesive vaginal gel products for infertility, pregnancy support, amenorrhea, and other women's health conditions, and a bioadhesive buccal system for male hypogonadism. Co. has partnered or sold each of these products for commercialization in various regions of the world. All of the products Co. has developed utilize its Bioadhesive Delivery System, which consists principally of a polymer (polycarbophil) and an active ingredient. According to our CBRX split history records, CBRX has had 1 split.
CBRX split history picture
CBRX (CBRX) has 1 split in our CBRX split history database. The split for CBRX took place on August 09, 2013. This was a 1 for 8 reverse split, meaning for each 8 shares of CBRX owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 125 share position following the split.

When a company such as CBRX conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share. Looking at the CBRX split history from start to finish, an original position size of 1000 shares would have turned into 125 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into CBRX shares, starting with a $10,000 purchase of CBRX, presented on a split-history-adjusted basis factoring in the complete CBRX split history. CBRX split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 03/23/2007
End date: 04/10/2015
Start price/share: $10.72
End price/share: $7.36
Dividends collected/share: $0.00
Total return: -31.34%
Average Annual Total Return: -4.56%
Starting investment: $10,000.00
Ending investment: $6,866.46
Years: 8.05
Date Ratio
08/09/20131 for 8
CBRX is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

CCM Split History
CDXC Split History
CELG Split History
CERE Split History
CGC Split History
CGNT Split History
CHDX Split History
CHE Split History
CHRS Split History
CLBS Split History

HEICO Corporation (HEI)
Tonix Pharmaceuticals Holding Corp. (TNXP)
Rosetta Genomics Ltd. (ROSG)
Condor Hospitality Trust, Inc. (CDOR)
Fibrocell Science, Inc. (FCSC)
VelocityShares Daily 2x VIX Medium Term ETN (TVIZ)
VelocityShares Daily 2x VIX Short Term ETN (TVIX)
VelocityShares VIX Short Term ETN (VIIX)
VelocityShares 3x Inverse Natural Gas ETN (DGAZ)
Wheeler Real Estate Investment Trust, Inc. (WHLR)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

CBRX Insider Buying

CBRX Split History | www.SplitHistory.com | Copyright © 2013 - 2017, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.